Kibur Medical develops an implantable, drug-eluting microdevice platform for in situ profiling of tumor responses to multiple oncology drugs or combinations
Kibur Medical develops an implantable, drug-eluting microdevice platform for in situ profiling of tumor responses to multiple oncology drugs or combinations. Its NanoNail™ enables multiplexed testing in intact tumors, with spatially registered, single-cell multi-omic data analyzed to identify effective therapies, drug mechanisms, and predictive biomarkers, supporting oncology drug discovery and clinical development.